Clinical Trial Update: Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Letrozole, Anastrozole, Exemestane, and Tamoxifen citrate in postmenopausal women with breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Exemestane (Exemestane)
• Letrozole (letrozole)
• Tamoxifen citrate (tamoxifen citrate)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED